A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...

Continuous glucose monitoring (CGM) is now the standard of care for people with type 1 diabetes in many countries, but its role in the management of type 2 diabetes is less well established. This is ...

Amadou Alpha Sall is a Senegalese virologist who worked for three decades at the Institut Pasteur de Dakar (IPD) before joining the Coalition for Epidemic Preparedness Innovations (CEPI), in 2025, as ...

The past 5 years have seen the strong momentum in youth engagement turn into many achievements worthy of celebration. When The Lancet Child & Adolescent Health launched its first Youth Advisory Panel ...

Kidney disease is a major global health issue with implications for the lives of millions of people and for the cost of health care. Yet there is surprisingly little public awareness about the ...

Despite substantial progress in malaria control over the past two decades, malaria caused by Plasmodium falciparum remains a leading cause of morbidity and mortality in sub-Saharan Africa, ...

We thank Ole Fröbert and colleagues for their interest in our study and proposing that vaccination might protect against cardiovascular disease through mechanisms beyond infection prevention, ...

Laura Mauldin's latest book begins with a story of falling in love. “I was the one”, she recalls of the start of her relationship with “J”. When J is diagnosed with leukaemia, Mauldin becomes not only ...